Sarcopenia is an age-related syndrome causing muscle loss, affecting 5-13% of individuals over 60. It leads to frailty and reduced quality of life, with muscle protein synthesis decline as a key mechanism. There is a critical need for novel drug development to restore muscle function and slow progression.